NEW YORK (GenomeWeb) – OncoDNA said today that it has entered into a new collaboration agreement with Mexican firm Zogen.

Under the deal, Zogen will market and promote OncoDNA's products to oncologists and their patients in Mexico. This includes molecular profiling of both liquid biopsies and solid tumor tissue to guide personalized medicine.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.